In summary, the deactivation of the Stat3-Bcl-2 pathway contributes to metformin-induced growth inhibition of ESCC by facilitating crosstalk between apoptosis and autophagy [54,55]. Here, BCL2 is linked to esophageal squamous cell carcinoma.